Hypothalamic Control of Adrenocorticotropin Secretion: Advances since the Discovery of 41-Residue Corticotropin-Releasing Factor

Clicks: 2
ID: 301717
1986
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #184 of 220 articles by views in endocrine reviews

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 220 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
IN THE 25 yrs after the first demonstration of CRF in hypothalamic tissue (1, 2), research on CRF progressed along two major lines of experimentation. In the context of a functional anatomical approach, researchers sought to elucidate the hypothalamic organization of neurons that produce CRF and control the secretion of ACTH (for reviews see Refs. 3–5). The second major trend was the quest for the isolation and chemical characterization of the hypothalamic CRF principle (for reviews see Refs. 6–8). It was the discovery of 41-amino acid residue CRF (CRF-41) by Vale and co-workers (9) which provided the missing link between the two major paths of investigation. Aided by decades of expertise accumulated in laboratories throughout the world, workers finally having the right stuff at hand rapidly established CRF-41 as a major physiological mediator of the hypothalamic control of ACTH secretion (for reviews see Refs. 10–12). However, it soon became evident that CRF-41 is not the sole hypothalamic neurohormone involved in the control of pituitary ACTH secretion (e.g. see Refs. 13–17). Thus, the second phase of CRF research, the post-CRF-41 era, had begun.
Reference Key
openalex_W2114608871 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors F. Antoni
Journal endocrine reviews
Year 1986
DOI
10.1210/edrv-7-4-351
URL
https://doi.org/10.1210/edrv-7-4-351
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.